Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China

por Li, Dandan, Peng, Linna, Xing, Shishi, He, Chunjuan, Jin, Tianbo
Publicado 2021

Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population

por He, Chunjuan, Peng, Linna, Xing, Shishi, Li, Dandan, Wang, Li, Jin, Tianbo
Publicado 2021

The Impacts of IL1R1 and IL1R2 Genetic Variants on Rheumatoid Arthritis Risk in the Chinese Han Population: A Case–Control Study

por Liu, Xiaoli, Peng, Linna, Li, Dandan, He, Chunjuan, Xing, Shishi, Wang, Yuhe, He, Yongjun
Publicado 2021

Impacts of LOC105371267 Variants on Breast Cancer Susceptibility in Northern Chinese Han Females: A Population-Based Case-Control Study

por Peng, Linna, Huang, Congmei, Xing, Shishi, Li, Dandan, He, Chunjuan, He, Yongjun, Yang, Wei, Jin, Tianbo, Wang, Li
Publicado 2021

Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China

por Wang, Yuliang, Peng, Linna, Lu, Hongyan, Zhang, Zhanhao, Xing, Shishi, Li, Dandan, He, Chunjuan, Jin, Tianbo, Wang, Li
Publicado 2021

Fc receptor-like 1, 3, and 6 variants are associated with rheumatoid arthritis risk in the Chinese Han population

por Yang, Yonghui, Li, Dandan, He, Chunjuan, Peng, Linna, Xing, Shishi, Bai, Mei, Rong, Hao, Yuan, Dongya, He, Yongjun, He, Xue, Wang, Li, Jin, Tianbo
Publicado 2021